In conclusion, our results suggest a mechanism by which FRMD3 interacts with vimentin and ubiquitin ligase UBE3A through its ubiquitin-like domain to promote proteasome degradation of vimentin, thereby exerting a unique function of FRMD3 in breast cancer progression. Here, UBE3A is linked to breast carcinoma.